Network pharmacology and in vitro experiments-based strategy to investigate the mechanisms of KangXianYiAi formula for hepatitis B virus-related hepatocellular carcinoma

• Main Authors: Xu Cao (Author), Hening Chen (Author), Zhiguo Li (Author), Xiaoke Li (Author), Xianzhao Yang (Author), Qiushuo Jin (Author), Yijun Liang (Author), Jiaxin Zhang (Author), Meiyue Zhou (Author), Ningyi Zhang (Author), Guang Chen (Author), Hongbo Du (Author), Xiaobin Zao (Author), Yong'an Ye (Author)
• Format: Book
• Published: Frontiers Media S.A., 2022-09-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

The Chinese traditional medicine KangXianYiAi formula (KXYA) is used to treat hepatic disease in the clinic. Here we aim to confirm the therapeutic effects and explore the pharmacological mechanisms of KXYA on hepatitis B virus (HBV)-related hepatocellular carcinoma (HCC). We first collected and ana...